Here are the biggest calls on Wall Street This Week:

Evercore ISI reiterates Apple as outperform

Evercore said Apple is defensive.

“AAPL offers a different earnings driver through iPhone mix/pricing and Services rather than data-center construction; our work points to resilient demand, with gross-margin recovery and price elasticity the key tests. This is THE name to keep working when investors want to get defensive.”

Bank of America Reiterates Nvidia as Buy

Bank of America maintained its Buy rating on Nvidia (NVDA), describing the chipmaker as best-in-class in the rapidly growing AI computing and networking markets.

The bank set a $350 price target, based on 22 times its estimated calendar 2027 earnings per share, excluding cash.

BofA said Nvidia's leading market position justifies its valuation, while noting potential risks from uneven global AI investment projects, cyclical gaming demand and constraints on electricity availability.

Morgan Stanley Reiterates SpaceX as Overweight

Morgan Stanley maintained its Overweight rating on SpaceX, describing the recent share-price weakness following the U.S. midterm elections as a potential buying opportunity.

The bank said some of the sell-off was driven by negative sentiment toward data centers. However, it argued that SpaceX's long-term business model could benefit from the expansion of AI into space and robotics, potentially opening up substantial new addressable markets.

Guggenheim Reiterates Netflix as Buy

Guggenheim maintained its Buy rating on Netflix (NFLX), identifying several potential catalysts for the streaming company's growth in 2027 and beyond.

The firm highlighted three key drivers: expanded sports and live-event programming, including an NFL game and the Women's World Cup in 2027; a renewed content strategy under new Chief Content Officer Peter Rice; and broader third-party partnerships.

Guggenheim believes these initiatives could improve investor sentiment in 2027 and support financial growth into 2028.

Barclays reiterates Advanced Micro Devices as overweight

Barclays said it’s sticking with the stock following earnings.

“AMD remains our favorite idea in the group as the CPU and GPU businesses accelerate in tandem.”

Evercore ISI reiterates Arm as outperform

Evercore said the company is a top idea following earnings.

“While we expect continued late cycle derate we continue to view ARM as a key beneficiary of our ‘CPU Renaissance’ thesis. Our price target is $372, based on P/E ratio of 23x our 2030 base case EPS of $21.55, discounted back three years.”

Deutsche Bank reiterates CoreWeave as buy

Deutsche Bank lowered its price target on CoreWeave.

“Right now, we believe the underlying fundamentals are being obscured by questions around financing that we are optimistic will be addressed over the next several quarters, presenting opportunity for investors. We reiterate our Buy rating while reducing our target price to $125 (from $150) to reflect somewhat higher near-term financing costs.”

Citi upgrades Coupang to buy from neutral

Citi said it sees plenty of positive catalysts ahead.

“We upgrade Coupang (CPNG) to Buy, given: 1) likely sequential improvement in adj. EBITDA from 4Q26; 2) developing offering biz likely being less of earnings headwind in 2027; and 3) EV to CPNG’s Korea e-commerce GMV ratio suggesting share price now at near floor value.”

Morgan Stanley downgrades Cisco to equal weight from overweight

Morgan Stanley said the bar is “higher” for additional upside.

“We continue to see a multi-year trajectory for DD growth, largely through cloud growth, helping CSCO sustain a higher multiple than historical. However, cautious of degree of pull forward ahead of pricing increases and margin profile of cloud business, causing us to step to the sidelines for now.”

Truist downgrades Nike to sell from hold

Truist said it sees too many negative catalysts for Nike.

“With numerous issues still at-play including (1) more retro Jordan product launches sitting on shelves/selling below retail, (2) limited visibility on where/when China bottoms, (3) tough comparisons and (4) an incrementally tougher outlook in Running (where they have had more success), we reit our $29 PT and are downgrading shares to Sell.”

BMO Initiates Astera Labs at Outperform

BMO initiated coverage of Astera Labs (ALAB) with an Outperform rating and a $375 price target, calling the company a leader in AI infrastructure.

Roth Upgrades Centrus Energy to Buy From Hold

Roth upgraded Centrus Energy (LEU) to Buy from Hold, saying it has become more constructive on the company's outlook.

The firm previously had concerns about an expected decline in revenue and the stock's elevated valuation, which it believed created significant downside risk. The upgrade suggests those concerns have eased.